Variation in the HLA-G Promoter Region Influences Miscarriage Rates
Overview
Authors
Affiliations
The HLA-G gene is primarily expressed in placental cells that invade the maternal decidua during pregnancy. This gene encodes multiple isoforms that fulfill a variety of functions at the maternal-fetal interface throughout gestation. Recently, a null allele for the most abundant HLA-G isoform was associated with recurrent miscarriage in two independent studies, suggesting that reduced levels of the HLA-G1 protein may compromise successful pregnancy. We initiated the present study to determine whether other polymorphisms that could affect expression levels of HLA-G were associated with fetal loss in women participating in a 15-year prospective study of pregnancy outcome. We genotyped these subjects for 18 single-nucleotide polymorphisms in the 1,300 bp upstream of exon 1, 13 of which were identified as part of this study, as well as for an insertion/deletion (in/del) polymorphism in the 3' untranslated region. The 18 SNPs defined eight unique haplotypes. One polymorphism, -725C/G, was associated with fetal loss, with an increased risk for miscarriage in couples in which both partners carried the -725G allele, compared with couples not carrying this allele (odds ratio 2.76, 95% confidence interval 1.08-7.09; P=.035). Further, the G at nucleotide -725 creates a CpG dinucleotide, and we demonstrate that this CpG site is methylated on -725G alleles. Overall, this study identified extraordinary levels of variation in the 5'-upstream regulatory region of HLA-G and provides evidence for an association between a promoter-region SNP and fetal loss rates, further attesting to the novel features and critical role of this gene in pregnancy.
Arumugam T, Adimulam T, Gokul A, Ramsuran V Front Immunol. 2024; 15:1422834.
PMID: 39355248 PMC: 11442197. DOI: 10.3389/fimmu.2024.1422834.
Maternal-Fetal Compatibility in Recurrent Pregnancy Loss.
Cuadrado-Torroglosa I, Garcia-Velasco J, Alecsandru D J Clin Med. 2024; 13(8).
PMID: 38673652 PMC: 11051463. DOI: 10.3390/jcm13082379.
Cao C, Bai S, Zhang J, Sun X, Meng A, Chen H Med Rev (2021). 2023; 2(6):570-589.
PMID: 37724255 PMC: 10471095. DOI: 10.1515/mr-2022-0030.
Hu L, He D, Zeng H Front Immunol. 2022; 13:988370.
PMID: 36532068 PMC: 9751038. DOI: 10.3389/fimmu.2022.988370.
Adolf I, Almars A, Dharsee N, Mselle T, Akan G, Nguma I Genes Dis. 2022; 9(5):1220-1233.
PMID: 35873024 PMC: 9293715. DOI: 10.1016/j.gendis.2021.06.004.